*Please inquire the availability for this product. Pseudoerythromycin A enol ether is a degradation product of erythromycin formed by a complex internal rearrangement of erythromycin A on exposure to neutral to weakly alkaline conditions. The C6–OH forms an internal enol ether with the C9 ketone of erythromycin, while the C11-OH attacks the carbonyl of the lactone to reduce the macrocycle from a 14- to an 11-membered macrolide. Synthetically, pseudoerythromycin A enol ether is prepared by reacting erythromycin enol ether with carbonate. Pseudoerythromycin A enol ether is devoid of antibiotic activity but is an important analytical standard for erythromycin A stability studies.

Additional Information

Product #	P-2791
CAS #	105882-69-7
Formula	C37H65NO12
MW	715.9
Appearance	White solid
Purity	>98% by HPLC
Solubility	Soluble in ethanol, methanol, DMF or DMSO Good water solubility
Storage Temp	-20°C
Use	Pseudoerythromycin A enol ether is a degradation product of erythromycin

Additional Information

MDL Number	MFCD09841212
InChI	InChI=1S/C37H65NO12/c1-14-25(39)37(10,43)32-20(4)28-18(2)16-36(9,50-28)31(49-34-27(40)24(38(11)12)15-19(3)45-34)21(5)29(22(6)33(42)48-32)47-26-17-35(8,44-13)30(41)23(7)46-26/h19-27,29-32,34,39-41,43H,14-17H2,1-13H3/t19-,20+,21+,22-,23+,24+,25-,26+,27-,29+,30+,31-,32-,34+,35-,36-,37-/m1/s1
SMILES	O=C4O[C@@H]([C@@](O)(C)[C@H](O)CC)[C@H](C=1O[C@](C)(CC=1C)[C@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@H]([C@H](O[C@@H]3O[C@H]([C@H](O)[C@](OC)(C3)C)C)[C@H]4C)C)C